These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33017484)

  • 1. Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
    Gergi M; Landry KK; Ades S; Barry M; Zakai NA; Herrera DA
    Oncologist; 2020 Dec; 25(12):1009-1012. PubMed ID: 33017484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab-induced thrombotic thrombocytopenic purpura.
    Dickey MS; Raina AJ; Gilbar PJ; Wisniowski BL; Collins JT; Karki B; Nguyen AD
    J Oncol Pharm Pract; 2020 Jul; 26(5):1237-1240. PubMed ID: 31718453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy.
    Lancelot M; Miller MJ; Roback J; Stowell SR
    Transfusion; 2021 Jan; 61(1):322-328. PubMed ID: 33119913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment strategy for patients with thrombotic thrombocytopenic purpura].
    Yagi H
    Rinsho Ketsueki; 2021; 62(8):1222-1228. PubMed ID: 34497210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2021; 62(5):480-485. PubMed ID: 34248125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura.
    Joly BS; Coppo P; Veyradier A
    Blood; 2017 May; 129(21):2836-2846. PubMed ID: 28416507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
    Kubo K; Abe T; Kawano N; Ochiai H
    Am J Case Rep; 2021 Aug; 22():e932251. PubMed ID: 34334786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
    Al-Husban N; Al-Kuran O
    J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel.
    Rivkin A
    Pharmacotherapy; 2007 Jul; 27(7):1058-61. PubMed ID: 17594212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
    Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
    J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma.
    Mullally WJ; Cooke FJ; Crosbie IM; Kumar S; Abernethy VE; Jordan EJ; O'Connor M; Horgan AM; Landers R; Naidoo J; Calvert PM
    Front Immunol; 2022; 13():871217. PubMed ID: 35514990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
    Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
    BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer.
    Yoshida Y; Toriyabe S; Imai H; Sasaki K; Kasahara Y; Ouchi K; Saijo K; Onodera K; Ishioka C
    Intern Med; 2024 Oct; 63(19):2667-2671. PubMed ID: 38432967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P; Veyradier A
    Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of thrombotic thrombocytopenic purpura].
    Kubo M; Matsumoto M
    Rinsho Ketsueki; 2020; 61(5):529-535. PubMed ID: 32507820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS13 deficiency and thrombotic thrombocytopenic purpura associated with trimethoprim-sulfamethoxazole.
    Bapani S; Epperla N; Kasirye Y; Mercier R; Garcia-Montilla R
    Clin Med Res; 2013 Jun; 11(2):86-90. PubMed ID: 23262188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura.
    Roose E; Joly BS
    Hamostaseologie; 2020 Aug; 40(3):322-336. PubMed ID: 32726827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.